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Micromanipulation at an
infertility centre
Aim. Human in vitro fertilisation (IVF) and gamete intra-
fallopian transfer have been used in the management of
various forms of infertility. In cases of severe male-factor
infertility, fertilisation can be a factor. In this study
micromanipulation was used to increase fertilisation in
such cases.
Methods. Two micromanipulation techniques, subzonal
sperm injection (SUZI) and partial zona dissection (PZD),
were used to assist fertilisation in patients with abnorTl)al
semen parameters. Ten couples with severe oligo-, terato-
and asthenozoospermia participated in the SUZI
programme. Seventy-three oocytes were obtained from
these 10 patients. PZD was used on day 1 oocytes in
cases of male infertility as well as a rescue attempt on day
2 oocytes when fertilisation had failed after routine
insemination.
Results. The SUZI technique had a fertilisation rate of
37,7%. In this group, a biochemical pregnancy was
achieved. Differences between the fertilisation rate of
conventionallVF (33,3%) and PZD (56,3%) in cases of
male infertility, were not statistically significant although a
clinical difference could be detected. PZD was statistically
effective in facilitating fertilisation (37,5% v. 8,3%) in
couples where this procedure was introduced to
reinseminate 24-hour-old unfertilised oocytes. Four
patients received PZD reinseminated embryos. An average
of 1,45 PZD embryos were replaced and 1 implantation
pregnancy was confirmed.
Conclusion. The micromanipulation results are
encouraging arid seemed to increase the efficiency of IVF
in humans. Furthermore, our data support the conclusion
that micromanipulation procedures can bring about
pregnancies.
S Afr Med J 1995; 85: 36-40.
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In vitro fertilisation (IVF) is effective in the management of a
variety of infertility problems. However, many cases of male
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infertility are refractory to IVF. In the case of men, fertilisation
is a highly inefficient process, as a result either of failure of
sperm to pass through the zona pellucida or of an inhibition
of sperm/oocyte interactions.'·3 Through microsurgical
manipulation, the barriers to sperm penetration can be
circumvented.
Three micromanipulation techniques are currently used to
assist fertilisation: (I) injection of a single sperm directly into
the ooplasm (OSI); (il) sub-zonal injection (SUZI) of 1 - 5
spermatozoa into the perivitelline space (PVS); or (iil) a
method whereby a hole or incision is mechanically drilled
into the zona - partial zona dissection (PZO). Each method
has yielded live offspring in animal studies.4' 6 Human
pregnancies have been achieved and infants born,
seemingly without any abnormalities, with the I,ast two
methods!,3.]
Having mastered the time-consuming methods of
micromanipulation and encouraged by recent successes
with PZO and SUZI, we were successful in obtaining
permission from the relevant ethics committee to introduce
micromanipulation as an accepted form of management for
male infertility. This study reports on the methodology used
to perform PZO and SUZI on micromanipulated ,
reinseminated 1-day-old oocytes, producing morphologically
normal embryos. We also present results of successful
fertilisation and implantation in consenting patients with




Before entering the programme, all patients were given an
extensive consultation to explain the techniques, the lack of
information, on these novel procedures and the expected
outcome of the different methods.
Most patients were stimulated with a combination of
clomiphene citrate (CC; Serophene: Serono, Rome, Italy)
100 mg daily on days 4 through 8 of the woman's cycle, as
well as follicle-stimulating hormone (FSH) (Metrodin: Serono,
Rome, Italy) usually 150 IU a day on days 5 - 8 and/or
human menopausal gonadotrophin (hMG) (Pergonal: Serono,
Rome, Italy). We individualised our stimulation programme
according to hormone levels and the patient's response to
treatment. In some cases the stimulation was a combination
of gonadotrophin-releasing hormone agonist (GnRH-a)
(Buserelin nasal spray) and hMG or FSH. Patients were
monitored sonographically from day 9 of their cycles until
the leading follicle was 14 mm long. Ovulation was induced
by means of 10 000 IU of human chorionic gonadotrophin
(hCG) (Profasi: Serono, Rome, Italy) when the leading follicle
reached 18 mm.
A single culture medium (Earle's bicarbonate~buffered .
medium) was used. The medium was tested for endotoxlns
by means of the Limilus Amebocyte Lysate Test, and the
mouse embryo test was also performed. This medium was
used for preparation of semen, oocyte culture,
micromanipulation, insemination and embryo culture and
replacement. The culture medium was supplemented with
heat-inactivated maternal serum. On the day of egg




Medium supplementation was increased to 15% serum for
zygote culture and to 75% at the time of embryo
replacement. Oocytes and embryos were cultured in organ
culture dishes (Falcon 2025) and maintained at 37°C in a
gas concentration of 5% CO2 ,
Semen preparation
Semen specimens were collected after a period of
abstinence (3 days) by masturbation into a single-specimen
cup. The sperm were prepared by means of a modified
swim-up method. The semen sample was evaluated and the
total volume of semen put in a 15 ml test tube (Falcon
3033). The semen was layered with approXimately 5 ml of
10% serum-supplemented medium. The semen and medium
were mixed by gentle pipetting of the mixture up and down.
The semen was centrifuged for 10 minutes at 1 700 rpm.
The upper layer was gently removed and the sperm pellet
resuspended in 1 ml of the incubation medium for the
routine IVF and PZO procedures; for the SUZI procedure, a
1:1 ratio of culture medium and patients' pre-ovulatory
follicular fluid was used to resuspend the sperm pellet. The
sperm was incubated for 6 hours, after which the medium
in the upper layer was removed, washed and centrifuged at
1 500 rpm for 10 minutes; the final sperm pellet was
resuspended in fresh medium.
The semen of 11 patients with oligozoospermia (> 1 x
106/ml and < 87 x 106/ml) and/or severe teratozoospermia
(normal morphology < 4%) and/or positive mixed antibody
reaction (MAR) and/or a history of IVF failure but with a
normal percentage of motile sperm (motility> 40%) were
prepared for PZO. This procedure was also undertaken in a
further 6 patients in whom no fertilisation was seen 16 hours
after primary insemination.
Ten patients were allocated to SUZI because of severe
oligozoospermia « 2 x 106/ml), teratozoospermia (normal
forms < 4%) and asthenozoospermia (motility < 40%).
Preparation of oocytes
After the oocytes were collected, they were placed in serum-
supplemented culture medium and incubated at 37°C in 5%
CO2 • Within 2 hours each oocyte cumulus complex was
exposed to 0,1 % hyaluronidase (Sigma, sheep testes type
111, St. Louis, Mo.) dissolved in Earle's balanced salt
solution for 4 - 5 minutes at 37°C. These exposed oocytes
were rinsed 3 - 4 times in EBSS. The remaining corona
radiata cells were removed manually with hypodermic
needles, and gently aspirated through a finely pulled Pasteur
pipette. Great emphasis was placed on the complete
removal of adhering corona radiata, given the tendency of
these cells to attach to glass surfaces and thus interfere with
micromanipulation procedures. Most of the oocytes included
in this study had completed metaphase 11, and a polar body
was scored. Before micromanipulation was initiated the
cytoplasm was shrunk by means of 0,1 M sucrose (Sigma,
St. Louis, Mo.). One oocyte at a time was transferred to an
indented glass slide and covered with light liquid paraffin.
After the procedure was completed, the oocyte was rinsed
three times and incubated under standard conditions.
Between 17 and 19 hours later the oocytes were scored for
the presence of pronuclei and transferred to 15% serum-
supplemented medium.
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Table 11. Clinical data on the male factor in the SUZI group




Patients (%) (%) (million/ml) Others
A 2 Normal 87 History
B 2 Normal 3 Positive
MAR
C 3 Normal 1
0 2 Normal 20
E 1 Normal 65
F 2 25 1
G 4 Normal 18
H 3 Normal 32
I 3 Normal 17 Positive
MAR
J 4 Normal 20
K 2 Normal 5
Normal motility: > 40% motile sperm.
Manufacture of the instruments
Micropipettes and microneedles were prepared from glass
capillary tubes containing an inner filament. Cleaning of the
capillaries was facilitated by their being soaked overnight in
1% 7X detergent, and rinsed 20 times in Saxter water before
being dried in a hot air oven. The capillaries were then dry-
heat sterilised for 2'/2 hours.
Micropipettes and microneedles were pulled with a
Narishige vertical pipette puller (Narishige PS-7, Tokyo,
Japan). Sharper microneedles were pulled by heating of a
small glass bead which was melted onto the element of the
Narishige microforge (Model MF-9, Tokyo, Japan). With
sufficient heat, the bead was fused onto the underside of
the tip of the pulled pipette. As soon as the fusion had
occurred and before any distortion could take place the
pipette was pulled upwards and the element switched off.
Upon making of the suction or holding pipette, the tip of the
pipette was nipped off and the uneven edges ground away
with a Narishige grinding wheel. The tip of the holding
pipette was then reduced to a diameter of approximately
20 ~m by melting the tip in front of a white-hot microforge
element. Microneedles were pulled and the tip was ground
to a diameter of 15 ~m and a 30 - 35° bevel with the
grinding wheel. The tip of this injection pipette was
sharpened with the glass bead and microforge. Micro-
manipulations were performed on an inverted Olympus
microscope (MT-2, Tokyo, Japan) with Narishige
micromanipulators (Model 201, Tokyo, Japan).
Micro-instruments were fitted to the micromanipulators by
means of a tool holder. The Teflon tubing and the micro-
instrument were filled with light liquid paraffin oil by means
























































Oocytes were clamped by suction onto the holding pipettes.
A microneedle pierced one side of the oocyte and the
oocyte was moved slightly upwards with the microneedle, in
order to avoid contact between the holding pipette and the
microneedle. The zona pellucida was pierced a second time.
The suction was continued while the microneedle was
forced upwards away from the holding pipette, causing
small apertures in the zona. The microneedle was removed
by the pulling thereof from the zona while suction of the
oocyte with the holding pipette continued. At times the
procedure was repeated on a different side of the oocyte.
PZD in cases of male infertility
Sixty-five oocytes were collected from the partners of 11
patients with male infertility (Table 11). The collections were
performed via transvaginal ultrasound-guided aspirations.
Three to 6 hours after egg collection, approximately 50% of
each patient's oocytes were randomly allocated for
micromanipulation. After sucrose removal, the
micromanipulated eggs and the control oocytes were
separately inseminated with 1 - 2 x 105 motile
spermatozoa/mI. These oocytes were checked for pronuclei
and polar bodies during the 15 - 18 hours following
insemination.
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NlR =morphological evaluation not reliable due to small volume.
PZD for reinsemination
Twenty-eight 1-day-old unfertilised oocytes from 6 patients
were randomly divided into 2 groups. The oocytes of the 1
group were subjected to PZO before reinsemination, while
the oocytes of the remaining group were reinseminated
without any micromanipulation. Fertilisation results of the
PZO procedure were compared with those where
conventional reinsemination was performed. All
micromanipulated and control oocytes were reinseminated
with the original sperm suspension; there were
approXimately 1 x 105 spermatozoa/mI.
The SUZI procedure
The spermatozoa were aspirated from a droplet (on an
indented glass slide) into the tip of the injection pipette. One
oocyte was present in a culture drop adjacent to the drop
containing the spermatozoa. Once the sperm was aspirated
into the pipette, the slide was moved to visualise the oocyte
in the adjacent drop. The oocyte was held by negative
pressure from the holding pipette, and the injection needle
forced through the zona pellucida into the PVS. One to 3
sperm were released into the PVS. Care was taken not to




The 10 couples participating in this procedure were
patients with severe oligozoospermia, asthenozoospermia
and teratozoospermia (Table 11). All 73 oocytes retrieved from
the patients were cultured until the first polar body was
detected; they were then subjected to SUZI.
developed into a transferable embryo. An average of 1,45
PZO embryos were replaced and one implantation
pregnancy was confirmed (Table V).
Table IV. Fertilisation and cleavage rate of reinseminated zona-
intact and partial zona-dissected t-day-old oocytes
Zona-intact oocytes PZO oocytes
• Fertilisation and cleavage rates did not differ significantly (P > 0,05).
Table Ill. The outcome of oocytes after PZD
ResuJts
PZD in cases of male infertility
Comparisons between conventional and PZO insemination
are statistically valid, as the oocytes were derived from the
same group of 11 patients and all oocytes were exposed to
hyaluronidase, hypodermic needle dissection and sucrose.
The results of PZO prior to insemination on randomly
collected oocytes from male-factor infertility patients are
given in Table Ill. Comparison between the fertilisation rate
of conventional (33,3%) and PZO (56,3%) inseminations are
not statistically significant although a clinical difference can
be detected. The incidence of polyspermia was 5% in the
PZO group, while no polyspermia occurred in the control
group. The proportion of monospermic embryos available for
replacement was higher when PZO was applied (66,7% v.
45,5%). Six per cent of the oocytes micromanipulated on
day 1 were damaged. The oocytes were ruptured when the
microneedle was inserted, but in two cases this happened
when the vitellus was obscured by corona cells (Table Ill).
Two patients received a combination of PZO and untreated
embryos, while 3 patients had 2 PZO embryos replaced and
6 patients had no replacements. Although fertilisation was
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• pnc = two pronuclei evident
t aborted after 6 weeks
• Fertilisation and cleavage rates differ significantly (P < 0,05).
Ten patients underwent successful oocyte recovery with a
view towards the use of the SUZI technique to achieve IVF.
The various semen analyses presented at the time of
oocyte recovery ranged from a total count of 0,1 x 10s/ml
(9 patients) to 1 patient with 1,3 x 106/ml and normal
morphology between 1% and 4%. From these patients
73 oocytes were obtained and exposed to hyaluronidase.
Of the 73 oocytes treated by means of SUZI, 5 (6,8%) were
immature; 12 oocytes (16,4%) were damaged during this
procedure.
Eight of the patients (80%) had at least 1 oocyte fertilised
by means of SUZI and 5 (50%) had replacement (Table VI).
Twenty-four oocytes were fertilised (39,3%) and 1 was
polyspermic (4,2%). The patients fell into 2 groups: those 3
who had transcervical embryo replacement, and those 2
who had a zygote intra-fallopian tubal transfer. In the latter





Table V. Incidence of cleavage and pregnancy in patients with
embryo transfers after the reinsemination of 24-hour-old oocytes,






















All patients in this group had severe teratozoospermia
(normal morphology < 4%) but the motility of the sperm
was in most cases above 40%. The sperm count of 4 of
the patients was < 5 x 106/ml, another 4 patients had a
count between 17 x 1D6/ml and 20 x 10'/ml and the count
of the 3 remaining patients varied between 32 x 1D'/ml and
87 x 10'/ml.
PZD for reinsemination
As shown in Table IV, PZO was statistically effective in
facilitating fertilisation (37,5% v. 8,3%) (P < 0,05) in couples
where this procedure was introduced to reinseminated
24-hour-old unfertilised oocytes. Fertilisation was not
achieved in 1 patient, and in another patient was achieved
but with no further embryo development. Four patients
received PZO embryos. None of the untreated oocytes
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Discussion
All patients entering the programme were informed in detail
about the nature of the procedures and the limited success
rate. In most major IVF programmes, fertilisation rates of
70% are typical." However, lower fertilisation rates per
oocyte (7,3%) were reported by Kruger and co-workers'
when normal morphology was below 4%. We report a
fertilisation rate of 56,3% for the PlO group with normal
morphology of below 4%. The fertilisation and embryo
development achieved in this study compare favourably with
similar studies.11l-12 It must be understood that the fertilisation
rate after PlO, although higher than it would be without PlO
(56,3% v. 33,3%), is still low for many patients. The efficacy
of this procedure could be questioned, given that several
oocytes were fertilised in the same patient without PlO
being used. However, in 3 of the 11 (27,3%) attempts,
fertilisation would not have taken place if PZO had not been
used.
Malter and Cohen 13 developed the PlO technique; this
process resulted in pregnancies, albeit in patients with
lesser degrees of infertility than those reported in our study.
Our efforts with PlO have not yielded ongoing pregnancies,
i.e. patients who have not yet delivered, but have passed
their first trimester. Analysis of our results indicates that
losses incurred at the fertilisation and cleavage stages result
in a reduced number of embryos being available for
transferral. This reduced the chance of achieving a
pregnancy.
PlO can also be employed as a rescue attempt where
conventional in vitro insemination has failed. Mature human
oocytes can remain viable for more than 24 hours and may
still be fertilised and develop into normal embryos.
Unfertilised oocytes may be inseminated again the day after
oocyte collection, in a procedure called reinsemination.
The current results indicate that the unfertilised oocytes
from regular IVF patients have the potential to be fertilised
after PlO. PlO did effectively increase the monospermic
fertilisation rate following reinsemination to 37,5%, which is
slightly higher than the 25% reported by Malter et al." None
of the untreated oocytes cleaved, while some of the PlO
oocytes developed into embryos and were transferred. A
pregnancy resulted from this group, but ended in an
abortion after 6 weeks.
Our data would seem to support the conclusion'that
exposure of oocytes to PZO could lead to pregnancy.
Sperm selection in the SUll procedure is a major
concern, particularly when a single spermatozoon is used; it
was difficult to obtain more than one sperm for injection.
There is always a possibility of selecting a genetically
abnormal spermatozoon for micro-insemination especially if
the male has poor semen.,·15.16 Chandley et al." reported a
chromosome abnormality rate of 15% in the sperm of sub-
fertile men. Another problem in sperm selection is to
determine whether the injected spermatozoon is capacitated
and acrosome-reacted or not. It has been well established
that only acrosome-reacted spermatozoa are capable of
fertilising oocytes.'8-2Q
When compared with many other reports, the incidence of
polyspermia (4,2%) in our study was not higher. The damage
rate (16,4%) in this study is near the average frequency for
other SUll programmes.3•21 Although our fertilisation rate is
higher (37,7% v. 15%) than the results published by Fishel
et al.,3 we find our cleavage rate to be relatively low (61,1 %
v. 96%). This may have resulted from fertilisation by
defective sperm. Ng et al. 22 strongly suggest that a factor
associated with the sperm quality contributed to this low
cleavage rate. However, our study shows an implantation
rate of 10%.
Although certain problems mentioned above remain to be
solved, the results of micromanipulation appear encouraging
and suggest that it is a powerful tool in increasing the
efficiency of IVF in humans.
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